CIBC Asset Management
SNTI icon

CIBC Asset Management’s Senti Biosciences Holdings SNTI Stock Holding History

CIBC Asset Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,320
Closed -$8.28K – 1094
2023
Q2 		$8.28K Hold
1,320
– – ﹤0.01% 1099
2023
Q1 		$15.6K Buy
+1,320
New +$20.5K ﹤0.01% 1064

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CIBC Asset Management's SNTI Position: Q3 2023 in Review

CIBC Asset Management sold out of Senti Biosciences Holdings (SNTI) in Q3 2023, closing a stake of 1,320 shares — an estimated $8.28K sold.

CIBC Asset Management first reported a position in SNTI in Q1 2023 and held it in 2 quarters. The position peaked at $15.6K in Q1 2023. 25 funds tracked by Wall St. Rank hold SNTI as of Q3 2023.

  • CIBC Asset Management reported no remaining Senti Biosciences Holdings position as of Q3 2023 after selling out during the quarter.
  • CIBC Asset Management sold 1,320 Senti Biosciences Holdings shares in Q3 2023, an estimated $8.28K.
  • CIBC Asset Management first reported a position in Senti Biosciences Holdings in Q1 2023 and held it in 2 quarters.
  • CIBC Asset Management's Senti Biosciences Holdings position peaked at $15.6K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2023.

Based on CIBC Asset Management's 13F filing for Q3 2023, filed 30 Oct 2023.